Detalhe da pesquisa
1.
JAK inhibitors in the treatment of adult patients with juvenile idiopathic arthritis: a retrospective monocentric experience.
Clin Exp Rheumatol
; 42(5): 974-982, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38530666
2.
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.
Ann Rheum Dis
; 81(5): 695-709, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34972811
3.
Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study.
Biomolecules
; 13(9)2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37759674
4.
Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine.
Arthritis Res Ther
; 24(1): 21, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35016701
5.
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort.
J Clin Med
; 11(13)2022 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35806873
6.
JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis.
Clin Rheumatol
; 39(3): 847-851, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31897953